[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.167.137. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 13, 1996

Smokers and Breast Cancer'Chemical Individuality' and Cancer Predisposition

Author Affiliations

From the Division of Medical Genetics, Department of Pediatrics, Harbor-UCLA Medical Center, Torrance, Calif.

JAMA. 1996;276(18):1511-1512. doi:10.1001/jama.1996.03540180067035
Abstract

What struck Archibald Garrod as black urine on a baby's diaper led to his book on inborn errors of metabolism (1909), viewed then as a small work on "obscure metabolic abnormalities."1,2 More ignored, however, was his idea on disease predisposition and person-to-person variation in biochemical traits, or "chemical individuality" (1931): "[I]n every case of every malady there are two sets of factors at work in the formation of the morbid picture, namely internal or constitutional factors, inherent in the sufferer and usually inherited from his forebears, and external ones which fire the train."3

See also p 1494.

Therefore, Garrod probably would have been pleased to see the article on N-acetyltransferase 2 (NAT2, or acetylator) enzymes, smoking, and breast cancer by Ambrosone et al4 in this week's issue of The Journal, because it follows his way of thinking about disease predisposition. The article suggests that defective acetylator

×